
|Videos|October 13, 2020
Dr. Ben Chew discusses kidney stones and metabolic syndrome
Author(s)Urology Times staff
"Treat the patient as a whole, not just as a stone former," Chew advises.
Advertisement
In this interview, Ben H. Chew, MD, MSc, associate professor of urologic sciences at the University of British Columbia, Vancouver, discusses findings from the recent Journal of Endourology paper, “Metabolic Syndrome Negatively Impacts Stone-Specific Quality of Life,” for which he served as a study author.
More videos:
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
3
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
4
EV plus pembro approval reframes first conversation in MIBC diagnosis
5













